A recent retrospective analysis of non-small cell lung cancer (NSCLC) patients treated with anti-PD-1 monotherapy demonstrated similar results: pre-treatment anti-Tg and/or anti-TPO antibodies were associated with the development of immune-related hypothyroidism, but not other irAEs39. The gene discussed is TG; the disease is non-small cell lung carcinoma.